ESTRADIOL AND PROGESTERONE RECEPTORS IN CULTURED NORMAL HUMAN BREAST EPITHELIAL-CELLS AND FIBROBLASTS - IMMUNOCYTOCHEMICAL STUDIES

被引:57
作者
MALET, C
GOMPEL, A
YANEVA, H
CREN, H
FIDJI, N
MOWSZOWICZ, I
KUTTENN, F
MAUVAISJARVIS, P
机构
[1] HOP NECKER ENFANTS MALAD, DEPT ENDOCRINOL & REPROD MED, 149 RUE SEVRES, F-75743 PARIS 15, FRANCE
[2] HOP NECKER ENFANTS MALAD, DEPT PATHOL, F-75743 PARIS 15, FRANCE
[3] HOP NECKER ENFANTS MALAD, DEPT BIOCHEM, F-75743 PARIS 15, FRANCE
关键词
D O I
10.1210/jcem-73-1-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The estradiol (E2) and progesterone (P) receptors (ER and PR) were studied in normal human breast epithelial (HBE) cells and fibroblasts cultured separately in our laboratory from surgical reductive mammoplasty samples. Immunocytochemical studies were performed on cytospun cells using the anti-ER antibody H222 Sp-gamma and the anti-PR antibodies JZB39 and KD68. A specific immunostaining was observed for ER and PR in HBE cells. This immunostaining was nuclear, varying from cell to cell in positivity and intensity of staining. Moreover, ER and PR immunostaining was hormone-modulated: it increased in E2-treated cells and decreased after addition of the progestin R5020. In fibroblasts, a weak ER immunostaining and a stronger PR immunostaining could be observed; however it was not modified by either E2 or progestogen treatment. Thus, in normal breast epithelial cells, E2 stimulates both its own receptor and PR, whereas the progestin R5020 lowers ER and PR content. In contrast, ER and PR content in normal breast fibroblasts seem to be independent of E2 or P action.
引用
收藏
页码:8 / 17
页数:10
相关论文
共 38 条
[1]  
BASSLER R, 1970, CURR TOP PATHOL, V53, P7
[2]   CYTOPLASMIC AND NUCLEAR ESTRADIOL AND PROGESTERONE RECEPTORS IN HUMAN ENDOMETRIUM [J].
BAYARD, F ;
DAMILANO, S ;
ROBEL, P ;
BAULIEU, EE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 46 (04) :635-648
[3]   PHENOL RED IN TISSUE-CULTURE MEDIA IS A WEAK ESTROGEN - IMPLICATIONS CONCERNING THE STUDY OF ESTROGEN-RESPONSIVE CELLS IN CULTURE [J].
BERTHOIS, Y ;
KATZENELLENBOGEN, JA ;
KATZENELLENBOGEN, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2496-2500
[4]   ESTROGENS STIMULATE CELL-PROLIFERATION AND INDUCE SECRETORY PROTEINS IN A HUMAN-BREAST CANCER CELL-LINE (T47D) [J].
CHALBOS, D ;
VIGNON, F ;
KEYDAR, I ;
ROCHEFORT, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (02) :276-283
[5]  
EISEN MJ, 1932, CANCER RES, V2, P1029
[6]   USE OF IMMUNOCYTOCHEMISTRY OF PROGESTERONE AND ESTROGEN-RECEPTORS FOR ENDOMETRIAL DATING [J].
GARCIA, E ;
BOUCHARD, P ;
DEBRUX, J ;
BERDAH, J ;
FRYDMAN, R ;
SCHAISON, G ;
MILGROM, E ;
PERROTAPPLANAT, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :80-87
[7]   PROGESTIN EFFECT ON CELL-PROLIFERATION AND 17-BETA-HYDROXYSTEROID DEHYDROGENASE-ACTIVITY IN NORMAL HUMAN-BREAST CELLS IN CULTURE [J].
GOMPEL, A ;
MALET, C ;
SPRITZER, P ;
LALARDRIE, JP ;
KUTTENN, F ;
MAUVAISJARVIS, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (05) :1174-1180
[8]  
GOMPEL A, 1985, BREAST DISEASE SENOL, V34, P149
[9]   ESTROGEN CONTROL OF PROGESTERONE RECEPTOR IN HUMAN BREAST-CANCER - ROLE OF ESTRADIOL AND ANTI-ESTROGEN [J].
HORWITZ, KB ;
KOSEKI, Y ;
MCGUIRE, WL .
ENDOCRINOLOGY, 1978, 103 (05) :1742-1751
[10]  
JACQUEMIER J, 1987, B CANCER, V74, P129